Pharmalot… Pharmalittle… Good Morning, Everyone

Make a comment

By Ed Silverman // October 22nd, 2007 // 7:07 am

sunrise2.jpgWelcome to the working week. Another busy day awaits us all - earnings will be reported shortly by another couple of big drugmakers. And the usual flow of tidbits is streaming our way. Get set…

Kirin In Talks To Buy Japanese Drugmaker (Bloomberg News)

Sanofi-Aventis’ Taxotere Gets Positive EU Opinion (Yahoo/Reuters)

Sequella Getting Orphan Drug Status For TB Product (The Washington Post)

New Safety Data Reported For J&J, Boston Scientific Stents (Bloomberg News)

Jump to comments

Share

Comments are closed.

Subscribe

RSS Feed

Comments feed for this post only.

Tags

« FDA’s Toll-Free Side-Effect Hotline Is Not In Service
AstraZeneca And China: The Outsourcing Begins »

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/